Shopping cart
Your cart empty!
Terms of use dolor sit amet consectetur, adipisicing elit. Recusandae provident ullam aperiam quo ad non corrupti sit vel quam repellat ipsa quod sed, repellendus adipisci, ducimus ea modi odio assumenda.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Dolor sit amet consectetur adipisicing elit. Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Sit amet consectetur adipisicing elit. Sequi, cum esse possimus officiis amet ea voluptatibus libero! Dolorum assumenda esse, deserunt ipsum ad iusto! Praesentium error nobis tenetur at, quis nostrum facere excepturi architecto totam.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Inventore, soluta alias eaque modi ipsum sint iusto fugiat vero velit rerum.
Do you agree to our terms? Sign up
Men with suspected prostate cancer will be able to get an NHS diagnosis within a day as part of a new trial.
Artificial intelligence will be used to interpret MRI scans, meaning problematic lesions can be detected in a matter of minutes. Should a scan conclude there is a high risk of cancer, it will be sent to a radiologist for priority review - with the patient booked in for a biopsy that same day.
NHS England says the AI tool will be trialled at up to 15 hospitals to begin with, though only Leeds Teaching Hospital will trial the faster one-day "rapid diagnosis" pathway. It is an approach that could save men months of waiting.
At present, men with suspected prostate cancer are meant to receive an MRI and a biopsy within a week of being referred by their GP. However, waiting times can be longer depending on the capacity of radiologists.
Tech 'revolutionising' NHS Health Secretary Wes Streeting said prostate cancer is a "devastating disease" - and long waits for test results, diagnosis, and treatment are "needlessly distressing" for patients. "By harnessing the power of technology we are revolutionising our NHS and tackling this, with AI able to deliver same-day prostate diagnoses, delivering better outcomes for patients and fast support for doctors," he added.
NHS England's national clinical director for cancer, Professor Peter Johnson, said the health service is "really excited by the potential of artificial intelligence". He explained: "As with all cancers, speed is crucial - the quicker the diagnosis, the sooner treatment can begin and help give the best chance of treatment being successful for patients and their families." The trial could be a "game changer.